CellWell record HH-12426
Zinc-L-Carnosine (Polaprezinc) in managing infant regurgitation: a two-center randomized controlled trial.
Piccirillo M; Mennini M; Felici E; Mauro A; Bernardo L; Baldassarre ME; Renzi E; De Vito C; Furio S; Graziani M; Quatrale G; Ferretti A; Di Nardo G
Frontiers in pediatrics ยท 2026
In plain language
A two-center, open-label randomized trial in infants with persistent regurgitation compared zinc-L-carnosine to thickened formula; parents knew the treatment given, so parent-reported outcomes may carry bias.
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-12426
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.